Completed PHASE2 INTERVENTIONAL 3-arm NCT03992144

Prevention of Dry Socket by Means of Single Preoperative Antibiotics Compared to Conventional Therapy

Prevention of Dry Socket by Means of Single Preoperative Oral Dose of Metronidazole and Amoxicillin Compared to Conventional Therapy

Sponsor: Dow University of Health Sciences

Conditions Dry Socket

Interventions Amoxicillin 500 Mg metronidazol 400mg and amoxicillin 500mg metronidazole 400mg

Updated 4 times since 2019 Last updated: Jun 18, 2019 Started: Oct 1, 2018 Primary completion: Jan 31, 2019 Completion: Apr 15, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03992144, this PHASE2 trial focuses on Dry Socket and remains completed. Sponsored by Dow University of Health Sciences, it has been updated 4 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jul 2019 — Jan 2021 [monthly]

Completed PHASE2

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dow University of Health Sciences

Data source: Dow University of Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karachi, Pakistan